These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 37501071)

  • 21. Dual optical recordings for action potentials and calcium handling in induced pluripotent stem cell models of cardiac arrhythmias using genetically encoded fluorescent indicators.
    Song L; Awari DW; Han EY; Uche-Anya E; Park SH; Yabe YA; Chung WK; Yazawa M
    Stem Cells Transl Med; 2015 May; 4(5):468-75. PubMed ID: 25769651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human Pluripotent Stem Cell-Derived Atrial and Ventricular Cardiomyocytes Develop from Distinct Mesoderm Populations.
    Lee JH; Protze SI; Laksman Z; Backx PH; Keller GM
    Cell Stem Cell; 2017 Aug; 21(2):179-194.e4. PubMed ID: 28777944
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human-induced pluripotent stem cell-derived cardiomyocytes from cardiac progenitor cells: effects of selective ion channel blockade.
    Altomare C; Pianezzi E; Cervio E; Bolis S; Biemmi V; Benzoni P; Camici GG; Moccetti T; Barile L; Vassalli G
    Europace; 2016 Dec; 18(suppl 4):iv67-iv76. PubMed ID: 28011833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-Throughput Drug Screening System Based on Human Induced Pluripotent Stem Cell-Derived Atrial Myocytes ∼ A Novel Platform to Detect Cardiac Toxicity for Atrial Arrhythmias.
    Honda Y; Li J; Hino A; Tsujimoto S; Lee JK
    Front Pharmacol; 2021; 12():680618. PubMed ID: 34413773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved Atrial Differentiation of Human Pluripotent Stem Cells by Activation of Retinoic Acid Receptor Alpha (RARα).
    Schwach V; Cofiño-Fabres C; Ten Den SA; Passier R
    J Pers Med; 2022 Apr; 12(4):. PubMed ID: 35455744
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug screening platform using human induced pluripotent stem cell-derived atrial cardiomyocytes and optical mapping.
    Gunawan MG; Sangha SS; Shafaattalab S; Lin E; Heims-Waldron DA; Bezzerides VJ; Laksman Z; Tibbits GF
    Stem Cells Transl Med; 2021 Jan; 10(1):68-82. PubMed ID: 32927497
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage-specific regulation of signalling pathways to differentiate pluripotent stem cells to cardiomyocytes with ventricular lineage.
    Satthenapalli R; Lee S; Bellae Papannarao J; Hore TA; Chakraborty A; Jones PP; Lamberts RR; Katare R
    Stem Cell Res Ther; 2022 May; 13(1):185. PubMed ID: 35524336
    [TBL] [Abstract][Full Text] [Related]  

  • 29.
    Rodríguez NA; Patel N; Dariolli R; Ng S; Aleman AG; Gong JQX; Lin HM; Rodríguez M; Josowitz R; Sol-Church K; Gripp KW; Lin X; Song SC; Fishman GI; Sobie EA; Gelb BD
    Circ Arrhythm Electrophysiol; 2024 Apr; 17(4):e012022. PubMed ID: 38415356
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Patch-Clamp Recording from Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes: Improving Action Potential Characteristics through Dynamic Clamp.
    Verkerk AO; Veerman CC; Zegers JG; Mengarelli I; Bezzina CR; Wilders R
    Int J Mol Sci; 2017 Aug; 18(9):. PubMed ID: 28867785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes.
    Cyganek L; Tiburcy M; Sekeres K; Gerstenberg K; Bohnenberger H; Lenz C; Henze S; Stauske M; Salinas G; Zimmermann WH; Hasenfuss G; Guan K
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous voltage and calcium mapping of genetically purified human induced pluripotent stem cell-derived cardiac myocyte monolayers.
    Lee P; Klos M; Bollensdorff C; Hou L; Ewart P; Kamp TJ; Zhang J; Bizy A; Guerrero-Serna G; Kohl P; Jalife J; Herron TJ
    Circ Res; 2012 Jun; 110(12):1556-63. PubMed ID: 22570367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A systemic evaluation of cardiac differentiation from mRNA reprogrammed human induced pluripotent stem cells.
    Mehta A; Verma V; Nandihalli M; Ramachandra CJ; Sequiera GL; Sudibyo Y; Chung Y; Sun W; Shim W
    PLoS One; 2014; 9(7):e103485. PubMed ID: 25068310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational investigation of electrophysiology in hypertrophic cardiomyopathy.
    Flenner F; Jungen C; Küpker N; Ibel A; Kruse M; Koivumäki JT; Rinas A; Zech ATL; Rhoden A; Wijnker PJM; Lemoine MD; Steenpass A; Girdauskas E; Eschenhagen T; Meyer C; van der Velden J; Patten-Hamel M; Christ T; Carrier L
    J Mol Cell Cardiol; 2021 Aug; 157():77-89. PubMed ID: 33957110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sophoridine manifests as a leading compound for anti-arrhythmia with multiple ion-channel blocking effects.
    Song T; Hao Y; Wang M; Li T; Zhao C; Li J; Hou Y
    Phytomedicine; 2023 Apr; 112():154688. PubMed ID: 36738478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Syncytium cell growth increases Kir2.1 contribution in human iPSC-cardiomyocytes.
    Li W; Han JL; Entcheva E
    Am J Physiol Heart Circ Physiol; 2020 Nov; 319(5):H1112-H1122. PubMed ID: 32986966
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
    Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional Impact of BeKm-1, a High-Affinity hERG Blocker, on Cardiomyocytes Derived from Human-Induced Pluripotent Stem Cells.
    De Waard S; Montnach J; Ribeiro B; Nicolas S; Forest V; Charpentier F; Mangoni ME; Gaborit N; Ronjat M; Loussouarn G; Lemarchand P; De Waard M
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32998413
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
    Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
    J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineered cocultures of iPSC-derived atrial cardiomyocytes and atrial fibroblasts for modeling atrial fibrillation.
    Brown GE; Han YD; Michell AR; Ly OT; Vanoye CG; Spanghero E; George AL; Darbar D; Khetani SR
    Sci Adv; 2024 Jan; 10(3):eadg1222. PubMed ID: 38241367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.